Vitale Elsa, Rizzo Alessandro, Halemani Kurvatteppa, Shetty Asha P, Cauli Omar, Massari Francesco, Santoni Matteo
Medical Thoracic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy.
S.S.D. C.O.r.O. Bed Management Presa in Carico, TDM, IRCCS Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco 65, 70124 Bari, Italy.
Biomedicines. 2025 May 13;13(5):1182. doi: 10.3390/biomedicines13051182.
Prostate cancer (PCa) represents the second-most common cancer among men worldwide. Obesity is generally considered as a risk factor for cancer and it has been associated with a 20-30% increased risk of PCa death. The present systematic review and meta-analyses aimed to highlight any existing trends between prostate neoplasm stages according to normal weight, overweight and obesity conditions. All interventional records such as randomized clinical trials, quasi-experimental studies and observational studies were included in the present systematic review and meta-analysis which reported PCa stages according to Gleason (GS) or TNM scores according to the BMI-related incidence, as normal weight, overweight and obesity groups. Twenty-nine studies were included in the present study. As regards the GS scoring system, 1.09% of high grade in GS was reported among PCa normal weights. Among PCa overweights, 0.98% of low grade was registered in GS. The same trend was recorded among obese PCa patients, since 0.79% of low grade in GS was also registered. As regards TNM scores, both normal weight, overweight and obese PCa patients registered a significant incidence in non-advanced TNM score, without any significant differences considering higher TNM assessments. Although the literature seemed to be more in favor of associations between BMI and GS, no specific mechanisms were highlighted between obesity and PCa progression. In this regard, the low androgen microenvironment in obese men could play an important role, but further studies will be necessary in this direction.
前列腺癌(PCa)是全球男性中第二常见的癌症。肥胖通常被认为是癌症的一个风险因素,并且它与前列腺癌死亡风险增加20%-30%相关。本系统评价和荟萃分析旨在突出根据正常体重、超重和肥胖情况划分的前列腺肿瘤分期之间的任何现有趋势。本系统评价和荟萃分析纳入了所有干预性记录,如随机临床试验、半实验性研究和观察性研究,这些研究根据BMI相关发病率,将前列腺癌分期报告为正常体重、超重和肥胖组,并根据 Gleason(GS)评分或TNM评分。本研究纳入了29项研究。关于GS评分系统,在前列腺癌正常体重患者中,报告的GS高级别为1.09%。在前列腺癌超重患者中,GS低级别记录为0.98%。在肥胖前列腺癌患者中也记录到了相同趋势,因为GS低级别也记录为0.79%。关于TNM评分,正常体重、超重和肥胖的前列腺癌患者在非晚期TNM评分中均有显著发病率,考虑到更高的TNM评估,没有任何显著差异。尽管文献似乎更倾向于BMI与GS之间的关联,但肥胖与前列腺癌进展之间没有突出具体机制。在这方面,肥胖男性的低雄激素微环境可能起重要作用,但在这个方向上还需要进一步研究。